About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ainos, Inc. - Common Stock (NQ:AIMD)

1.900 +0.040 (+2.15%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ainos, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

US Stocks Higher; Payrolls Increase By 216,000 In December ↗

January 05, 2024

U.S. stocks traded higher this morning, following the release of jobs data on Friday. Following the market opening Friday, the Dow traded up 0.08% to 37,470.26 while the NASDAQ rose 0.20% to 14,539.40....

Via Benzinga

Topics Stocks

Why Is Applied Therapeutics (APLT) Stock Down 30% Today? ↗

January 05, 2024

Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.

Via InvestorPlace

Why Is CISO Global (CISO) Stock Down 14% Today? ↗

January 05, 2024

CISO Global stock is falling on Friday as investors in the company react to a new delisting notice over the low trading price of the shares.

Via InvestorPlace

Why Is Dermata Therapeutics (DRMA) Stock Up 62% Today? ↗

January 05, 2024

Dermata Therapeutics stock is heading higher on Friday as investors of DRMA shares react to a new patent for DMT410 in Japan.

Via InvestorPlace

Topics Intellectual Property

Why Is Ainos (AIMD) Stock Up 157% Today? ↗

January 05, 2024

Ainos stock is up on Friday as shares of AIMD see heavy trading despite a lack of news from the healthcare company today.

Via InvestorPlace

AIMD Stock Earnings: Ainos Reported Results for Q1 2023 ↗

December 14, 2023

Ainos just reported results for the first quarter of 2023.

Via InvestorPlace

AIMD Stock Earnings: Ainos Reported Results for Q2 2023 ↗

December 14, 2023

Ainos just reported results for the second quarter of 2023.

Via InvestorPlace

AIMD Stock Earnings: Ainos Reported Results for Q3 2023 ↗

December 14, 2023

Ainos just reported results for the third quarter of 2023.

Via InvestorPlace

Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical

November 28, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 05, 2024

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket ↗

January 05, 2024

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of...

Via Benzinga

Topics Intellectual Property

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 05, 2024

Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!

Via InvestorPlace

Ainos Reports Third Quarter 2023 Financial Results

November 09, 2023

Via ACCESSWIRE

Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement

September 25, 2023

Via ACCESSWIRE

Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement

January 02, 2024

Via ACCESSWIRE

Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell

December 26, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 19, 2023

Via Benzinga

Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket ↗

December 18, 2023

Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in...

Via Benzinga

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 18, 2023

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 18, 2023

It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!

Via InvestorPlace

Ainos, Inc. Announces Stock Consolidation

December 12, 2023

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 22, 2023

Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest movements happening this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 21, 2023

Via Benzinga

Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

November 21, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 21, 2023

Via Benzinga

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 21, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.

Via Benzinga

With Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV Patients

September 19, 2023

Boston, Massachusetts--(Newsfile Corp. - September 19, 2023) - The U.S. Food and Drug Administration (FDA) has granted Ainos' (NASDAQ:...

Via Newsfile

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 18, 2023

Via Benzinga

Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients

September 18, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 15, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Ainos, Inc. - Common Stock (NQ:AIMD)

All News about Ainos, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us